CompareMarketResearchRequest a sample
Home / Healthcare / Urology Ablation Devices

Healthcare · Market report

Urology Ablation Devices Market Size, Share and Forecast 2026-2036

The global urology ablation devices market is worth USD 1.1 bn in 2026 and is forecast to reach USD 2.8 bn by 2036, growing at a 10.0% CAGR. United States is the largest country market and Cryoablation, HIFU and focused energy is the largest by technology segment.

USD 1.1 bnMarket size 2026
USD 2.8 bnForecast 2036
10.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global urology ablation devices market is worth USD 1.1 bn in 2026 and is forecast to reach USD 2.8 bn by 2036, growing at a 10.0% CAGR. United States is the largest country market and Cryoablation, HIFU and focused energy is the largest by technology segment.

ScopeDevices and single-use kits that destroy prostate, kidney and bladder tissue with heat, cold, water jet, laser or focused ultrasound, used in minimally invasive treatment of BPH and urologic tumours.
IndustryHealthcare
Value 2025USD 950 mn
Value 2026USD 1.1 bn
Value 2036USD 2.8 bn
CAGR 2026-203610.0%
Volume 2026434,627 procedures
Volume 20361,072,464 procedures
Average price 2026USD 2,448 per procedure
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Urology Ablation Devices market size and forecast, 2026-2036

Exhibit 1The global urology ablation devices market is forecast to grow from USD 1.1 bn in 2026 to USD 2.8 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 10.0%
Urology Ablation Devices market value, 2025 to 2036Market value by year. 2025: USD 950 mn; 2026: USD 1.1 bn; 2027: USD 1.2 bn; 2028: USD 1.3 bn; 2029: USD 1.4 bn; 2030: USD 1.6 bn; 2031: USD 1.7 bn; 2032: USD 1.9 bn; 2033: USD 2.1 bn; 2034: USD 2.3 bn; 2035: USD 2.5 bn; 2036: USD 2.8 bn. Compound annual growth rate 2026 to 2036: 10.0%.20251.1 bn20261.7 bn20312.8 bn203610.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 1.1 bn
2027USD 1.2 bn
2028USD 1.3 bn
2029USD 1.4 bn
2030USD 1.6 bn
2031USD 1.7 bn
2032USD 1.9 bn
2033USD 2.1 bn
2034USD 2.3 bn
2035USD 2.5 bn
2036USD 2.8 bn

Urology Ablation Devices market segmentation

By technology

Exhibit 2Cryoablation, HIFU and focused energy is the largest segment by technology, with 32.0% of 2026 revenueEstimated share of 2026 global revenue, by technology
Urology Ablation Devices market share by technology, 2026Share of 2026 revenue by technology. Cryoablation, HIFU and focused energy: 32.0%; Aquablation: 26.0%; Water vapour thermal ablation: 24.0%; Laser ablation and enucleation: 18.0%.Cryoablation, HIFU and focused energy32.0%Aquablation26.0%Water vapour thermal ablation24.0%Laser ablation and enucleation18.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Water vapour thermal ablation24.0%15.2%USD 255 mn5.1%
Aquablation26.0%47.7%USD 277 mn16.9%
Laser ablation and enucleation18.0%10.4%USD 192 mn4.1%
Cryoablation, HIFU and focused energy32.0%26.7%USD 340 mn8.0%

By application

Exhibit 3Benign prostatic hyperplasia adds the most revenue by application, growing from USD 724 mn in 2026 to USD 1.8 bn by 2036Estimated revenue in USD by application, 2026 and 2036 forecast
Urology Ablation Devices market by application, 2026 and 2036Revenue by application in 2026 and 2036. Benign prostatic hyperplasia: USD 724 mn in 2026, USD 1.8 bn in 2036, change +149%; Prostate cancer focal therapy: USD 170 mn in 2026, USD 606 mn in 2036, change +256%; Kidney and bladder tumours: USD 170 mn in 2026, USD 353 mn in 2036, change +107%.20262036 forecastChangeBenign prostatic hyperplasia+149%724 mn1.8 bnProstate cancer focal therapy+256%170 mn606 mnKidney and bladder tumours+107%170 mn353 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Benign prostatic hyperplasia68.0%65.3%USD 724 mn9.6%
Prostate cancer focal therapy16.0%21.9%USD 170 mn13.5%
Kidney and bladder tumours16.0%12.8%USD 170 mn7.6%

By energy

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Thermal44.0%40.0%USD 468 mn9.0%
Cryogenic22.0%20.0%USD 234 mn9.0%
Ultrasound focused14.0%18.0%USD 149 mn12.8%
Laser20.0%22.0%USD 213 mn11.1%

By access

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Transurethral60.0%58.0%USD 638 mn9.6%
Transperineal26.0%30.0%USD 277 mn11.6%
Percutaneous14.0%12.0%USD 149 mn8.3%

By setting

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospitals60.0%56.0%USD 638 mn9.2%
Ambulatory surgery centres28.0%30.0%USD 298 mn10.8%
Urology clinics12.0%14.0%USD 128 mn11.7%

Top 25 countries for urology ablation devices by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 88.0% of 2026 revenue and the 25 countries below together hold 96.4%.

Exhibit 4United States is the largest country market at USD 553 mn in 2026, and the three largest countries hold 64.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Urology Ablation Devices market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 553 mn, 52.0%; China: USD 64 mn, 6.0%; Germany: USD 64 mn, 6.0%; Japan: USD 64 mn, 6.0%; United Kingdom: USD 43 mn, 4.0%; France: USD 43 mn, 4.0%; Italy: USD 32 mn, 3.0%; Spain: USD 27 mn, 2.5%; Canada: USD 27 mn, 2.5%; South Korea: USD 21 mn, 2.0%.United States553 mn 52.0%China64 mn 6.0%Germany64 mn 6.0%Japan64 mn 6.0%United Kingdom43 mn 4.0%France43 mn 4.0%Italy32 mn 3.0%Spain27 mn 2.5%Canada27 mn 2.5%South Korea21 mn 2.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 553 mn52.0%USD 1.5 bn10.1%
2ChinaUSD 64 mn6.0%USD 240 mn14.2%
3GermanyUSD 64 mn6.0%USD 141 mn8.2%
4JapanUSD 64 mn6.0%USD 141 mn8.2%
5United KingdomUSD 43 mn4.0%USD 102 mn9.2%
6FranceUSD 43 mn4.0%USD 94 mn8.2%
7ItalyUSD 32 mn3.0%USD 69 mn8.0%
8SpainUSD 27 mn2.5%USD 58 mn8.1%
9CanadaUSD 27 mn2.5%USD 63 mn9.1%
10South KoreaUSD 21 mn2.0%USD 66 mn12.0%
11NetherlandsUSD 20 mn1.9%USD 48 mn9.2%
12AustraliaUSD 12 mn1.1%USD 28 mn9.2%
13SwitzerlandUSD 8.7 mn0.8%USD 21 mn9.2%
14BelgiumUSD 7.0 mn0.7%USD 17 mn9.1%
15SwedenUSD 6.0 mn0.6%USD 14 mn9.2%
16AustriaUSD 5.2 mn0.5%USD 12 mn9.1%
17TurkeyUSD 4.6 mn0.4%USD 16 mn13.1%
18MexicoUSD 4.2 mn0.4%USD 14 mn13.2%
19BrazilUSD 3.8 mn0.4%USD 13 mn13.0%
20IndiaUSD 3.5 mn0.3%USD 12 mn13.2%
21PolandUSD 3.3 mn0.3%USD 11 mn13.1%
22TaiwanUSD 3.1 mn0.3%USD 7.5 mn9.2%
23DenmarkUSD 2.9 mn0.3%USD 6.9 mn9.2%
24Saudi ArabiaUSD 2.8 mn0.3%USD 9.4 mn13.0%
25IsraelUSD 2.7 mn0.2%USD 8.8 mn12.8%
Rest of worldUSD 38 mn3.6%USD 94 mn9.4%
Exhibit 5United States and China account for 63% of the USD 1.7 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Urology Ablation Devices market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 1.1 bn. United States: +USD 898 mn; China: +USD 176 mn; Germany: +USD 77 mn; Japan: +USD 77 mn; United Kingdom: +USD 60 mn; 20 other countries: +USD 352 mn; Rest of world: +USD 56 mn. Market value 2036: USD 2.8 bn.Market value 20261.1 bnUnited States+898 mnChina+176 mnGermany+77 mnJapan+77 mnUnited Kingdom+60 mn20 other countries+352 mnRest of world+56 mnMarket value 20362.8 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Boston Scientific
  • Olympus
  • Teleflex

Group 2: Regional and specialist players

  • Procept BioRobotics
  • EDAP TMS
  • Medtronic
  • Lumenis
  • AngioDynamics
  • HistoSonics
  • IceCure Medical

Group 3: Emerging and niche players

  • Profound Medical
  • SonaCare Medical
  • Francis Medical

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the urology ablation devices market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 10.0% is calculated from the resulting values.

The market is divided by technology, by application, by energy, by access, by setting. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the urology ablation devices market?

The global urology ablation devices market is estimated at USD 950 mn in 2025 and USD 1.1 bn in 2026.

How fast will the urology ablation devices market grow?

It is forecast to reach USD 2.8 bn by 2036, a compound annual growth rate of 10.0% from 2026, an increase of USD 1.7 bn.

Which country is the largest market for urology ablation devices?

United States is the largest market by revenue at USD 553 mn in 2026, 52.0% of the global total. The three largest countries together hold 64.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 14.2% a year from 2026 to 2036.

Which urology ablation devices segment is largest?

In the by technology split, Cryoablation, HIFU and focused energy is the largest segment with 32.0% of 2026 revenue.

Who are the leading urology ablation devices companies?

Global leaders include Boston Scientific, Olympus, Teleflex.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Urgent Care Vaccine Cryoprotectants →

All Healthcare markets →

Request a sample